Ligand Pharmaceuticals Announces Conference Call to Discuss Final Results for First, Second and Third Quarters of Fiscal 2005
Posted on: Saturday, 10 December 2005, 00:00 CST
Ligand Pharmaceuticals Incorporated (Pink Sheets:LGND) will hold a conference call on Monday, December 12, 2005, at 8:30 a.m. Eastern Time (5:30 a.m. Pacific), to discuss its financial results for the first, second and third quarters of fiscal 2005.
The call will be web cast live and can be accessed on Ligand's web site at www.ligand.com, investor relations page, and www.streetevents.com.
About Ligand
Ligand discovers, develops and markets new drugs that address critical unmet medical needs of patients in the areas of cancer, pain, skin diseases, men's and women's hormone-related diseases, osteoporosis, metabolic disorders, and cardiovascular and inflammatory diseases. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology, primarily related to intracellular receptors. For more information, go to http://www.ligand.com.
Source: Business Wire
Related Articles
- CEL-SCI Presents Data at Prestigious Medical Conference Demonstrating That Its L.E.A.P.S. Technology Stimulates Maturation of Human Blood Cells Into Dendritic Cells Suggesting Potential for Prevention and Treatment of Infectious Disease
- Clopidogrel and Vascular Disease Prevention
- Ligand Announces TAP's Extension of R&D Collaboration Through June 2006
- Hormone Replacement Therapy and Peripheral Vascular Disease in Women
- Multiple Genetic Processes Result in Heterogeneous Rates of Evolution Within the Major Cluster Disease Resistance Genes in Lettuce(W)
- Bacterial Flagellin is a Dominant Antigen in Crohn Disease
- Fat Cells Fight Disease, Purdue University Researchers Find
- Current Applications of Flow Cytometry in the Diagnosis of Primary Immunodeficiency Diseases
- Podocyte biology and the emerging understanding of podocyte diseases
- Detection of ligand- and solvent-induced shape alterations of cell- growth
 |
 |
User Comments (0)
RSS Feeds